February 3, 2025
Financial Assets

Asset monetisation scheme 2.0 on the cards – Economy News

With the current National Monetisation Pipeline (NMP) programme ending in March this year, the Centre may announce its next phase with annual asset monetisation goals of Rs 2 lakh crore for the next 4-5 years, to mobilise capital for investments and re-investments. The government had set an ambitious Rs 6 trillion asset recycling target under

Read More
Financial Assets

Sensex Today | Stock Market LIVE Updates: Nifty 50, Sensex set for muted open, Dixon Tech, MCX to react to Q3 results

Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session higher. Nifty 50 closed at 23,344.75, while Sensex ended at 77,073.44. Sensex Today | Stock Market LIVE Updates: Nifty 50 ended the previous trade session 2,932.6 points away from its record high of 26,277.35. Asian markets

Read More
Intangible Assets

Federal Circuit Provides Guidance on What Claims Can Properly Serve As Obviousness-Type Double Patenting References

In a precedential decision issued on August 13, 2024, the U.S. Court of Appeals for the Federal Circuit held that a first-filed, first-issued, later-expiring claim cannot be invalidated by a later-filed, later-issued, earlier-expiring reference claim having a common priority date.1 Obviousness-Type Double Patenting Obviousness-type double patenting (ODP) is a judicially created doctrine dating back to

Read More
Fixed Assets

Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs – Bamboo Works

The developer of treatments for cancer and bone fractures is branching out into the weight-loss market, but faces strong competition there Key Takeaways: At present, Jiuyuan Gene relies heavily on a bone repair product, Guyoudao, for around half its revenue The company is developing a generic version of the weight-loss drug Semaglutide, which is undergoing

Read More